Quanterix

The ability to differentiate elevated cytokine and chemokine levels, such as IL-6, IL-1b, IL-10, IL-8, and TNFα, from healthy baseline with the highest level of precision is critical to SARS-Cov-2 research.

Quanterix’s Simoa technology enables researchers to measure infectious disease biomarkers.

Quanterix’s Simoa NfL Test kit measures NfL levels.

Quanterix product brochures describe technologies used to help researchers advance precision health in focused therapeutic areas.

The Quanterix blog covers biomarker detection and spatial biology news and research insights.

Publications Featuring the Simoa Accelerator Lab.

Spatial biology data sets created using ultrahigh-plex advanced spatial phenotyping in an interactive data gallery

Axios.com | Bryan Walsh, author of Future | May 15, 2021 Diagnostics that can identify biomarkers of disease in the blood are helping speed drug

The page describes the use of a blood test to detect the Alzheimer’s disease biomarker phosphorylated tau in research and clinical diagnosis.

Quanterix shares press releases, videos and blog posts.

There’s no simple way to tell who has Alzheimer’s disease, but with a blockbuster treatment for millions of Americans on the horizon, blood-test makers

Bill Donnelly chairs Quanterix’s Board of Directors. He has more than 20 years of senior leadership experience in life science tools and more than 25 years as a senior financial executive, including roles at Mettler-Toledo and Elsag Bailey Process Automation, NV.

Erica joined Quanterix in 2022 and has more than 25 years of HR experience. Her expertise includes change management and international HR, and she has developed global organizations and integrated corporate cultures.

Jeff has served as a director of Sera Prognostics, Inc. since March 2025 and as a consultant to The Boston Consulting Group since 2024. He was Chief Financial Officer of Exact Sciences Corp. from 2016 to May 2024 and Chief Operating Officer from 2021 to 2023.

The page describes a management team, scientists, investors and advisors working to advance precision health.

Quanterix aims to give researchers the ability to examine the continuum from health to disease.

Quanterix uses certified processes for the design, development, manufacturing and support of its instruments, assays and software.

Discovery Fueled by Ultra-Sensitivity

The Quanterix customer portal provides 24/7 access to assay and instrument information, troubleshooting solutions and user videos.

Quanterix’s Simoa biomarker testing technology helps researchers advance precision health.

The privacy and cookies policy describes how Quanterix Corporation handles information provided to it or collected through use of its website.

Buyer acknowledges that Quanterix’s sales representatives and other agents have no authority to make any representation or warranty not included in this Agreement or to modify or waive any provision of this Agreement.